Target intelligence / Profile preview

Extracellular matrix protein at wound site (ECM)

Target
ECM
Molecular classification
Other (structural protein network)
01

Overview

The "skin protein matrix at wound site" refers to the extracellular matrix (ECM) present within skin tissue during the wound healing process. This ECM is a complex and dynamic three-dimensional network composed primarily of proteins such as collagen (the most abundant structural protein in skin[5]), elastin, proteoglycans, and glycoproteins[1][2][3]. Following injury, the ECM is actively remodeled during all stages of wound healing—hemostasis, inflammation, proliferation, and remodeling. Its main functions include providing structural support for regenerating tissue, guiding cell migration, modulating the local bioavailability of growth factors, and serving as a physical barrier against pathogens[1][4]. The ECM composition at a wound site changes dynamically: provisional matrices are formed and replaced by more mature connective tissue as healing progresses. While the ECM at the wound site is critically important in healing, it is not a single molecular target but a complex ensemble of molecules, each with distinct regulatory pathways and potential as individual drug targets. Therefore, "skin protein matrix at wound site" is not a canonical term for a defined therapeutic target but a collective descriptor for the local extracellular matrix environment during skin repair[1][2].

Other names
skin protein matrixwound site ECMwound healing matrix
02

Biological functions

Tissue remodelingCell adhesionRegulation of cell migrationStructural supportModulation of growth factor activityImmune cell recruitment
03

Disease associations

Wound healing disordersFibrosisAbnormal scarring (hypertrophic scar, keloid)Skin inflammationInfection
04

Safety considerations

Challenging to modulate for therapy due to complexity and heterogeneityExcessive ECM deposition leads to scarring/fibrosisDegradation can cause chronic wounds or tissue weakness

Beyond the preview

Go deeper on Extracellular matrix protein at wound site (ECM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix protein at wound site (ECM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call